Structure Therapeutics Inc.

Structure Therapeutics Inc. (ticker: GPCR) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of GPCR's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 late-filing signal. GPCR reported no tagged revenue in revenue and -$75.97M for the period ending 2026-03-31, with operating cash flow of $15.23M. Cash and equivalents stood at $316.17M (up 107.8% year-over-year). Total assets of $1.51B exceed total liabilities of $61.03M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.